Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ)
300147.SZ Stock Price Chart
Explore Xiangxue Pharmaceutical Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 300147.SZ price movements and trends.
300147.SZ Company Profile
Discover essential business fundamentals and corporate details for Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Dec 2010
Employees
2.64K
Website
https://www.xphcn.comCEO
Yonghui Wang
Description
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. The company was founded in 1997 and is based in Guangzhou, China.
300147.SZ Financial Timeline
Browse a chronological timeline of Xiangxue Pharmaceutical Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 6 Jun 2025
Earnings released on 6 Jun 2025
EPS came in at -¥0.96 , while revenue for the quarter reached ¥325.10M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.13 , while revenue for the quarter reached ¥421.00M .
Earnings released on 29 Sept 2024
EPS came in at -¥0.13 , while revenue for the quarter reached ¥437.02M .
Earnings released on 30 Jun 2024
EPS came in at -¥0.15 , while revenue for the quarter reached ¥527.69M .
Earnings released on 7 Jun 2024
EPS came in at -¥0.38 , while revenue for the quarter reached ¥571.11M .
Earnings released on 31 Mar 2024
EPS came in at -¥0.05 , while revenue for the quarter reached ¥568.86M .
Earnings released on 29 Dec 2023
EPS came in at -¥0.11 , while revenue for the quarter reached ¥612.63M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.12 , while revenue for the quarter reached ¥526.83M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.01 , while revenue for the quarter reached ¥588.72M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.35 , while revenue for the quarter reached ¥441.47M .
Earnings released on 30 Sept 2022
EPS came in at -¥0.18 , while revenue for the quarter reached ¥554.61M .
Earnings released on 30 Jun 2022
EPS came in at -¥0.17 , while revenue for the quarter reached ¥577.27M .
Earnings released on 31 Mar 2022
EPS came in at -¥0.06 , while revenue for the quarter reached ¥613.72M .
Earnings released on 31 Dec 2021
EPS came in at -¥1.06 , while revenue for the quarter reached ¥734.12M .
Earnings released on 30 Sept 2021
EPS came in at -¥0.05 , while revenue for the quarter reached ¥700.94M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥744.58M .
Earnings released on 29 Apr 2021
EPS came in at -¥0.08 , while revenue for the quarter reached ¥577.63M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.04 , while revenue for the quarter reached ¥790.93M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.01 , while revenue for the quarter reached ¥678.00M .
300147.SZ Stock Performance
Access detailed 300147.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.